Table 3.
Factors | N | Resistant Genotype of Clarithromycin | Resistant Genotype of Levofloxacin | ||||
---|---|---|---|---|---|---|---|
Mutation Rate (%) | Univariate Analysis P value | Multivariate Analysis P value | Mutation Rate (%) | Univariate Analysis P value | Multivariate Analysis P value | ||
Gender | 0.260 | 0.400 | 0.359 | 0.334 | |||
Female | 256 | 41.0 | 28.1 | ||||
Male | 233 | 36.1 | 24.5 | ||||
Age | 0.083 | 0.036 | 0.009 | 0.040 | |||
<35 YO | 187 | 44.4 | 18.7 | ||||
35–50YO | 195 | 36.9 | 30.3 | ||||
>50YO | 107 | 31.8 | 32.7 | ||||
Clinical diagnosis | 0.138 | 0.220 | 0.849 | 0.868 | |||
PUD | 63 | 30.2 | 25.4 | ||||
NUD | 426 | 39.9 | 36.5 | ||||
Chronic atrophic gastritis | 0.241 | 0.341 | 0.001 | 0.044 | |||
CAG | 81 | 44.4 | 40.7 | ||||
Non-CAG | 408 | 37.5 | 23.5 | ||||
Intestinal metaplasia | 0.411 | 0.666 | 0.028 | 0.879 | |||
IM | 117 | 41.9 | 34.2 | ||||
Non-IM | 372 | 37.6 | 23.9 | ||||
Lymphoid aggregates | 0.333 | 0.304 | 0.430 | 0.590 | |||
Yes | 266 | 40.6 | 20.7 | ||||
No | 223 | 36.3 | 33.2 |
Abbreviations: PUD, peptic ulcer disease; NUD, non-ulcerative dyspepsia; CAG, chronic atrophic gastritis; IM, intestinal metaplasia.